Introduction {#Sec1}
============

Essential hypertension is defined as a rise in blood pressure which can increase risks for cerebral, cardiac, and renal events with unknown reason^[@CR1]^. Hypertension remains deserving for more attention since it is a potent risk factor for cardiovascular diseases and it may brings considerable morbidity and mortality^[@CR1]--[@CR4]^. Given the prevalence of hypertension in the population, early identifying subclinical left ventricular (LV) systolic dysfunction among hypertensive subjects might have an important role in assessing the prognosis and choosing treatment strategies.Strain imaging has emerged as a sensitive and powerful tool to detect early and subtle myocardial dysfunction in various cardiac diseases, and may provide a novel method for LV risk assessment in hypertensive patients^[@CR5]--[@CR7]^.

Myocardial strain was first used by cardiovascular magnetic resonance (CMR) tagging in 1988^[@CR8]^. CMR tagging has been the most available and reproducible method to quantify the myocardial deformation and remains the reference standard for evaluating myocardial strain^[@CR9],[@CR10]^. However, CMR tagging needs to acquire additional sequences and its post processing is time-consuming. The spatial resolution of tagging is quite low, which is another limitation of tagging. Therefore, CMR tagging has not yet been widely applied in clinical circumstances. Speckle tracking echocardiography (STE) has solved these issues to a large extent, but it is still limited by the observer dependency, signal noise, angle dependency, inadequate acoustic windows and poor image quality^[@CR11]--[@CR13]^. Cardiovascular magnetic resonance imaging feature tracking (CMR-FT), which derives from cine balanced steady-state free precession (bSSFP) sequence, has the advantages of measuring myocardial strain with no need for contrast agents or additional sequence acquisition, a wide field of view, no anatomic plane restriction, semi-automatic and time-saving post-processing procedure^[@CR14]--[@CR16]^. Hence, CMR-FT has been increasingly used as a novel non-invasive technique for the quantitative evaluation of myocardial function^[@CR17]^.

The aims of the study were to identify subclinical global systolic function abnormalities in hypertensive subjects using CMR-FT, and evaluate influencing factors associated with left ventricular strain parameters for hypertensive patients.

Results {#Sec2}
=======

Study population {#Sec3}
----------------

The study has comprised of 57 hypertensive patients (Age: 43.04 ± 10.90 y; 35 males) and 26 healthy volunteers (Age: 38.69 ± 10.44 y; 11 males). The distributions of clinical and demographic parameters of the two groups showed in Table [1](#Tab1){ref-type="table"}. Systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure (MAP) of the hypertension group were significantly higher than the healthy group, and hypertensive patients tended to have higher weight, body mass index (BMI), body surface area (BSA) and dyslipidemia compared with healthy group.Table 1Distributions of clinical and demographic parameters of the study population.Hypertensivepatients (*n* = 57)Healthy group (*n* = 26)*P* valueAge (year)43.04 ± 10.9038.69 ± 10.440.092Male (%)35(61.4)11 (42.3)0.105Height (m)1.68 ± 0.081.67 ± 0.070.389Weight (kg)76.09 ± 14.2864.81 ± 10.10\<0.001BMI (kg/m^2^)26.74 ± 3.3723.33 ± 3.06\<0.001BSA (m^2^)1.88 ± 0.211.72 ± 0.160.001Clinic SBP (mmHg)146.11 ± 13.44110.96 ± 6.00\<0.001Clinic DBP (mmHg)92.63 ± 10.2971.96 ± 4.78\<0.001MAP (mmHg)110.46 ± 10.7684.96 ± 4.84\<0.001Totalserumcholesterol (mmol/l)4.56 ± 0.814.05 ± 0.660.006Triglycerides (mmol/l)1.58 (1.13--2.53)1.33 (1.01--1.64)0.044LDL cholesterol (mmol/l)2.49 ± 0.752.14 ± 0.490.014HDL cholesterol (mmol/l)1.02 ± 0.281.35 ± 0.25\<0.001Hemoglobin A1C (%)5.74 ± 0.415.67 ± 0.350.373Fasting blood glucose(mmol/l)4.68 ± 0.564.76 ± 0.430.490Heart rate (beats/min)72.73 ± 9.9068.35 ± 7.900.051

Comparison of variables between the two groups was performed by using the *Mann-Whitney U* test for triglycerides, the *Chi square* test for sex, and the independent-sample Student's *t* test for other variables. BMI, body mass index; BSA, body surface area; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure, LDL cholesterol, low density lipoprotein cholesterol; HDL cholesterol, high density lipoprotein cholesterol.

Myocardial deformation by feature tracking {#Sec4}
------------------------------------------

There were no significant differences in LV end-diastolic volume indexed (EDVI), LV end systolic volume indexed (ESVI) and LVEF between the two groups, except for LV mass indexed (LVMI) (Table [2](#Tab2){ref-type="table"}).Table 2Comparison of left ventricular parameters of CMR in two groups.Hypertensivepatients (*n* = 57)Healthy group (*n* = 26)*P* valueIndexed LVEDV (ml/m^2^)63.59 ± 10.1766.71 ± 7.710.168Indexed LVESV (ml/m^2^)23.54 ± 5.8823.09 ± 3.860.678LVEF (%)63.19 ± 6.1865.42 ± 4.130.056Left ventricle mass/Height (g/m)70.49 ± 13.2453.38 ± 9.21\<0.001Left ventricle mass /BSA (g/m^2^)63.13 ± 10.7951.47 ± 7.05\<0.001GRS (%)35.14 ± 7.2742.14 ± 7.80\<0.001GCS (%)−19.64 ± 2.46−21.87 ± 2.42\<0.001GLS (%)−16.48 ± 2.34−17.85 ± 1.830.010Comparison of variables between the two groups was performed by using the independent-sample Student's t test. Indexed LVEDV, Indexed left ventricular enddiastolic volume; Indexed LVESV, Indexed left ventricular end-systolic volume; LVEF, left ventricular ejection fraction; BSA, body surface area; GRS, global radial strain; GCS, global circumferential strain; GLS, global longitudinal strain.

Compared with the control group, hypertensive patients had significantly reduced LV myocardial deformations mirrored by global radial strains (GRS), global circumferential strains (GCS) and global longitudinal strains (GLS) (Table [2](#Tab2){ref-type="table"}, Fig. [1](#Fig1){ref-type="fig"}). In univariable linear regression analyses in the hypertensive population, reduced GRS, GCS and GLS were all associated with MAP (*β* = −0.331, 0.121, and 0.09, respectively) and LVMI (LVM/BSA) (*β* = −0.366, 0.125, and 0.081, respectively) (Table [3](#Tab3){ref-type="table"}, Fig. [2](#Fig2){ref-type="fig"}).Figure 1Scatter dot plots reporting the comparison of the differences in hypertensive patients and healthy controls for global radial strain (GRS) (**a**), global circumferential strain (GCS) (**b**) and global longitudinal strain (GLS) (**c**). The black lines represents the mean with *SD*. The GRS, GCS and GLS were significantly different between the two groups. \**P* \< 0.05. GRS indicates global radial strain; GCS indicates global circumferential strain; GLS indicates global longitudinal strain.Table 3Univariable correlations of GRS, GCS and GLS in the hypertensive patients.GRSGCSGLS*βP* value*βP* value*βP* valueAge (year)−0.0370.6810.0140.6560.0450.12Male (%)−4.2880.0291.3360.0451.3960.027Height (m)−33.1150.00610.7270.0099.3550.017Weight (kg)−0.1460.0310.0470.0390.0410.059BMI (kg/m^2^)−0.3720.2010.1190.2240.1070.255BSA (m^2^)−10.4460.023.3730.0262.9680.04Clinic SBP (mmHg)−0.2280.0010.086\<0.0010.0750.001Clinic DBP (mmHg)−0.348\<0.0010.124\<0.0010.0840.005MAP (mmHg)−0.331\<0.0010.121\<0.0010.0900.001Totalserumcholesterol (mmol/l)−1.9490.1030.5350.1880.2990.441LDLcholesterol (mmol/l)−0.9170.4870.2850.5230.1230.773HDL cholesterol (mmol/l)6.3340.07−2.4160.04−0.8150.474Hemoglobin A1C (%)−1.3740.5630.6380.4260.2570.737Fasting blood glucose (mmol/l)−1.1880.4970.3230.5850.5840.298Heart rate (beats/min)−0.1480.1330.0590.0770.0230.466Left ventricle mass/Height (g/m)−0.314\<0.0010.107\<0.0010.0720.002Left ventricle mass /BSA (g/m^2^)−0.366\<0.0010.125\<0.0010.0810.004GRS, global radial strain; GCS, global circumferential strain; GLS, global longitudinal strain; BMI, body mass index; BSA, body surface area; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure, LDL cholesterol, low density lipoprotein cholesterol; HDL cholesterol, high density lipoprotein cholesterol.Figure 2Scatter plots of global radial strain (GRS) (**a**), global circumferential strain (GCS) (**b**) and global longitudinal strain (GLS) (**c**) against mean arterial pressure (MAP), linear regression estimates with 95% confidence limits (black lines with gray shades). GRS indicates global radial strain; GCS indicates global circumferential strain; GLS indicates global longitudinal strain; MAP indicates mean arterial pressure.

After multivariable regression analyses adjustment for confounders including age, sex, BSA, high density lipoprotein cholesterol (HDLC) and LVMI, the associations with MAP remained significant for GRS, GCS and GLS (Table [4](#Tab4){ref-type="table"}). In multivariable regression models, GRS and GCS had a negative association with MAP and LVMI; a negative association was revealed between GLS and Age, but the association of GLS with LVMI was attenuated after adjustment for confounders, however, GLS maintained a negative association with MAP (Table [4](#Tab4){ref-type="table"}). The above results showed that the increased blood pressure may have an adverse effect on myocardial strains, and the decrease of GRS and GCS strains was also associated with the increased LVMI, and GLS may decrease with age.Table 4Multiple Linear Regression Analysis of Left Ventricular Strain in Hypertension Group.GRSGCSGLS(*R*^2^ = 0.464, Adjusted *R*^2^ = 0.4, *F* = 7.219, *P* \< 0.001)(*R*^2^ = 0.499, Adjusted *R*^2^ = 0.439 *F* = 8.291, *P* \< 0.001)(*R*^2^ = 0.353, Adjusted *R*^2^ = 0.289 *F* = 5.563, *P* \< 0.001)*βP* value*βP* value*βP* valueAge (year)−0.0540.4960.0180.4740.0650.021Male0.0750.972−0.120.8660.5790.446BSA (m^2^)−9.1320.0713.0130.0683.1980.07MAP (mmHg)−0.2190.0090.0840.0020.0770.009HDL cholesterol (mmol/l)4.2540.129−1.7440.058------Left ventricle mass/BSA(g/m^2^)−0.2240.0150.0730.0150.0160.602GRS, global radial strain; GCS, global circumferential strain; GLS, global longitudinal strain; BSA, body surface area; MAP, mean arterial pressure, HDL cholesterol, high density lipoprotein cholesterol.

In our study, all segments were available to be tracked. Intra- and inter-observer variabilities were showed in Table [5](#Tab5){ref-type="table"}. All strain parameters had intra- and inter-observer *ICC* of ≥0.85, the reproducibility of the circumferential and longitudinal strain was better than that of the radial strain. The *Bland-Altman* plots of intra- and inter-observer agreement were displayed in Fig. [3](#Fig3){ref-type="fig"}.Table 5Intra- and inter-observer agreement in strain measurement.Mean differenceLimits of agreement*ICC*(95% *CI*)**GRS**Intra-observer0.46−4.15--5.070.946 (0.871--0.978)Inter-observer−0.49−8.44--7.460.898 (0.762--0.958)**GCS**Intra-observer−0.18−1.05--0.680.978 (0.944--0.991)Inter-observer0.05−1.16--1.260.977 (0.939--0.991)**GLS**Intra-observer−0.25−1.50--1.000.970 (0.923--0.988)Inter-observer0.03−0.85--0.910.960 (0.902--0.984)GRS, global radial strain; GCS, global circumferential strain; GLS, global longitudinal strain.Figure 3*Bland-Altman* plots of the intra- and inter-observer reproducibility for GRS (**a,d**), GCS (**b,e**) and GLS (**c,f**) measured by CMR-FT. The *Bland-Altman* plots include the line of equality, the line of mean difference, the lines of the 95% confidence interval of mean of differences and the lines of the 95% limits of agreement. GRS indicates global radial strain; GCS indicates global circumferential strain; GLS indicates global longitudinal strain.

Discussion {#Sec5}
==========

The main findings of the study were that (1) The hypertensive patients were inclined to have higher weight, BMI, BSA, serum lipids and LV mass. (2) The myocardial strain valueshad already significantly impaired before EF, EDVI and ESVI appeared abnormal in hypertensive patients. (3) There were a negative association between MAP and reduction of GRS, GCS and GLSwhen adjusting for key confounders of LV myocardial dysfunction, including age, sex, BSA, HDLC and LVMI in hypertensive patients. (4) All the strain parameters above had good reproducibility.

LVEF has been recognized as the routine prognostic parameter and reference standard of LV global systolic function. However, LVEF is only a representative of LV geometric change other than the function change^[@CR18]^, which indicates EF may be inaccessible to identify subtle and mild degrees of LV systolic abnormalities^[@CR19]--[@CR23]^. Maciver *et al*. reported that although longitudinal systolic strain had been reduced, EF may be normal by compensated with the increased radial wall thickness in LV hypertrophy^[@CR24]^. Our results showed that hypertensive patients had significantly reduced myocardial strains in early normal EF stage compared with control subjects, which confirmed the value of the strain in detection of early and subtle myocardial impairment with previous studies^[@CR25]--[@CR29]^.

The reason that reduced GRS, GCS and GLS were all independently associated with MAP may be that long-standing hypertension cause microscopic changes such as increased collagen turnover, myocardial fibrosis and subendocardial ischemia which lead to impaired strain, as other study explained^[@CR30],[@CR31]^. Saeed *et al*.^[@CR27]^ reported reduced GLS was particularly associated with hypertension and Navarini *et al*.^[@CR25]^ reported 3D strains had the similar results. Our results indicated GRS and GCS both had a negative association with LVMI (LVM/BSA). Higher BP could result in LV hypertrophy (LVH) which had increased LVMI^[@CR32]^. LV hypertrophy secondary to pressure overload is a compensation for high intracavitary pressures for maintaining normal wall stress and cardiac output^[@CR33]--[@CR35]^. According to our results, the process of myocardial hypertrophy may have been accompanied by the decrease of radial and circumferential strains. In addition, our results showed that GLS may decrease with age. Kaku *et al*. also found that GLS have significant age dependency, with the highest value in infancy and a gradual reduction with age^[@CR36]^. The age-related association with GLS may reveal the process of myocardial maturation and aging. Recently, the association of reduced strain with poor prognosis in hypertension was reported by Lee *et al*.^[@CR37]^. Despite the established role of LVEF and increased LV mass for higher incidence of cardiovascular risk^[@CR20],[@CR32],[@CR35],[@CR38]^, more and more studies showed strain (especially LV longitudinal strain) was superior and incremental for assessing the relation with major adverse cardiac events (MACE)^[@CR39]--[@CR41]^.

The normal reference values of strain parameters by using CMR-FT varied in different study. The discrepancies among different studies may attribute to different applied vendor or software version, as well as different patient characteristics such as age, sex, BMI, BP and HR^[@CR42]--[@CR44]^. For example, for healthy adults, Hwang *et al*. reported left ventricular GCS value was comparable to our result, but the values of left ventricular GRS and GLS were higher than that in our study^[@CR45]^. Thus, the normalization and standardization of strain parameters are required. In recent years, the reproducibility of LV strains by using CMR-FT had been proved^[@CR46]--[@CR48]^. Our results showed good reproducibility for all global strain parameters with intra- and inter-observer ICC of ≥0.85, the reproducibility of the circumferential and longitudinal strains was better than that of the radial strain. Our outcomes were consistent with the previous studies^[@CR16],[@CR46],[@CR49],[@CR50]^. The good reproducibility of the strain may owe to the advantages of superior image quality and accurate definition of the endocardial border, as well as the algorithm by using automated process and background smoothing^[@CR17],[@CR46]^. For the comparatively lower reproducibility of radial strain, the likely reason is that radial strain is derived from both endocardial and epicardial motion which is different with circumferential strain and longitudinal strain, and that the contrast of the epicardial signal intensity is less clear than that of the endocardial signal intensity^[@CR46]^. In addition, the accuracy of the strain parameters by using CMR-FT could be validated by comparing with CMR tagging. Good agreement with CMR tagging had been proved^[@CR14],[@CR51]^.

Limitations {#Sec6}
===========

The main limitations of this study were that: First, our study was limited by the relatively small number of subjects, which made it impossible for subgroup analysis with and without LV hypertrophy. Second, although several factors were incorporated toevaluate the associations with strains, there are other possible important confounders such as the application of antihypertensive drugs that have not yet been assessed. Thus, our results should be interpreted in the circumstances of the limitations, and it may be difficult to generalize our results. Of course, larger patient populations and more confounders should be performed to confirm our initial results.

Conclusions {#Sec7}
===========

Myocardial strain can early detect the myocardial damage and may be an appropriate target for preventive strategies because it occurs before abnormalities of EF. Among essential hypertensive patients, increased MAP may have an adverse effect on LV myocardial strains. CMR-FT may have potential to quantitatively analyze cardiac motion and apply in routine clinical practice in the future.

Methods {#Sec8}
=======

Study population {#Sec9}
----------------

The prospective study enrolled 57 participants with a diagnosis of essential hypertension from our hospital between October 2017 and October 2018. The patients had normal EF (≥50%) and no history or clinical evidence of cardiovascular disease. Hypertension was defined as a history of hypertension, use of antihypertensive medicines, or the values ≥130 mmHg SBP and/or ≥80 mmHg DBP according to the 2017 guideline^[@CR52]^. The patients had BP measurements using an automated electronic sphygmomanometer (HBP-9020, OMRON, Dalian, China). According to the 2017 guideline^[@CR52]^, after a minimum 5-min rest without caffeine, exercise, or smoking for at least 30 min in sitting position, blood pressure measurements were performed three times consecutively at 1--2 min intervals. Then, the individual's level of BP was calculated by the average of three measurements. Clinical and laboratory data were also obtained. The exclusion criteria includedsymptoms of chest pain or a history of coronary heart disease, myocardial infarction, cardiomyopathy, severe valvular disease, arhythmia, heart failure, severe obstructive lung disease, stroke, diabetes, kidney disease, thyroid disease and hypohemia. The patients who had contraindications for CMR such as claustrophobia, implantable not CMR safe materials, severe mental disorder were also excluded. In addition, we recruited 26 healthy volunteers as a control group for matching age and sex with case group. Volunteers with any of the symptoms and signs or a history of cardiovascular diseases, cerebrovascular diseases or relevant noncardiac diseases were excluded. All of the volunteers had normal blood test results.Written informed consent was obtained from all study participants. The study was approved by the ethics committee of central China Fuwai hospital. All methods were performed in accordance with the guidelines and regulations of the Declaration of Helsinki.

CMR image acquisition {#Sec10}
---------------------

All imaging was performed on a 3.0 Tesla MRI scanner (Magnetom Skyra, Siemens Healthcare, Erlangen, Germany) using an 18-channel cardiac phased-array receiver coil with patients in the supine position. Cine images were acquired using a standard balanced steady state free precession (bSSFP) sequence with retrospective electrocardiogram-gating in short axis (SAX) views from base to apex of the LV and long axis 2-, 3- and 4-chamber views. To cover the entire LV, 8 to 12 short-axis slices were performed with 4 to 6 breath-holds. All cine images were acquired with 25 phases per cardiac cycle. The scan parameters were: repetition time (TR) 3.2 ms, echo time (TE)1.40 ms, temporal resolution 44.66 ms, spatial resolution 1.8 × 1.8 mm, field of View (FOV) 369 × 369 mm, matrix 208 × 146, flip angle 49°, slice thickness 8 mm, slice gap 2 mm, acceleration factor 3.

CMR strain analysis {#Sec11}
-------------------

### Feature tracking {#Sec12}

Images were analysed by an experienced radiologist blinded to the patients' situations. CMR-FT analysis was performed using dedicated post-processing software (CVI^[@CR42]^ version 5.9.1, Circle Cardiovascular Imaging, Calgary, Canada). The endo- and epicardial border lines were marked automatically and trimmed manually in the end-diastolic phase (reference phase) on SAX slices. By using a maximum likelihood method, the software algorithm automatically drew the borders and traced the myocardium voxel points throughout the other cardiac phases during a cardiac cycle based on the endo- and epicardial contours of reference phase. The borders could be manually adjusted if inadequate tracking. Finally, the 2D strain values were calculated with the movement of the features relative to the reference phase^[@CR53]^ (Fig. [4](#Fig4){ref-type="fig"}). The short axis cine images were used to obtain GCS and GRS. The 4-chamber, 2-chamber, 3-chamber long-axis cine images were used to obtain GLS. LV volumes (end-diastolic and end-systolic volumes), LV myocardial mass and function (LVEF) were calculated from the short-axis cine images.Figure 4LV feature tracking analysis (1) Iidentify end-diastolic phase (reference phase); (2) The endo- and epicardial borders were automatically drew in the end-diastolic phase using SAX slices (**a-e**) and long axis 2-, 3- and 4-chamber slices (**f**--**h**), which could be manually adjusted if poor tracking; (3) Then, the software algorithm automatically drew the borders and traced the myocardium voxel points throughout the other cardiac phases during a cardiac cycle based on the endo- and epicardial contours of reference phase; (4) Finally, the 2D strain values were calculated automatically.

### Reproducibility {#Sec13}

Intra- and inter-observer variabilities of the measurements of GRS, GCS and GLS of 20 subjects randomly selected from the two groups (10 patients and 10 volunteers) were evaluated by two independent blinded observers. For intra-observer variability, the interval time between the two measurements is one month. For inter-observer variability, the two separate observers were blind to each other's measurements.

### Statistical analyses {#Sec14}

Statistical analyses were performed with SPSS statistics 22 (IBM corporation, USA) and MedCalc15.2.2 (MedCalc Software, Ostend, Belgium). Normal distribution of variables was assessed by *Shapiro-Wilk W* test. Continuous variables with normal distribution were presented as mean ± standard deviations, continuous variables with nonnormal distribution were presented as median with interquartile range (IQR). Categorical variables were presented as percentages. Comparisons of variables between the hypertensive patients and the controls were performed by using the independent-sample Student's *t*-test for normally distributed continuous variables, the *Mann-Whitney U* test for non-normally distributed continuous variables and the *Chi square* test for categorical variables. Univariable and multivariable linear regression analyses were used to evaluate the associations between LV strain parameters and the influencing factors. Covariates for multivariate models were selected based on the significant variables in the univariable analysis (*p* \< 0.20) and clinically relevant parameters. For reproducibility evaluation, intraclass correlation coefficient (*ICC*) and *Bland-Altman* plots were calculated. A *P* value of \<0.05 was considered statistically significant.

**Publisher's note** Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The authors are grateful to Haitao You (PhD, director of business development of Asia Market, Circle Cardiovascular Imaging) for reviewing language of the manuscript.

H.N.L. and Y.H.G. designed the study. H.N.L. analyzed statistics and interpreted the patient data. H.N.L., J.J.W. and Y.K.P. collected data. H.N.L. wrote the manuscript. Y.H.G., Z.P.G. and S.H.Z. revised the manuscript. All authors read and approved the final manuscript.

The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.

The authors declare no competing interests.
